Weiyin Lin

705 total citations
16 papers, 358 citations indexed

About

Weiyin Lin is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Weiyin Lin has authored 16 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Infectious Diseases and 6 papers in Hepatology. Recurrent topics in Weiyin Lin's work include Hepatitis C virus research (6 papers), Hepatitis B Virus Studies (5 papers) and COVID-19 Clinical Research Studies (4 papers). Weiyin Lin is often cited by papers focused on Hepatitis C virus research (6 papers), Hepatitis B Virus Studies (5 papers) and COVID-19 Clinical Research Studies (4 papers). Weiyin Lin collaborates with scholars based in China, United States and Taiwan. Weiyin Lin's co-authors include Fengyu Hu, Linghua Li, Zhiwei Xie, Chunyan Wen, Xilong Deng, Feng Li, Weiping Cai, Yujuan Guan, Yaping Wang and Jian Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Cold Spring Harbor Perspectives in Biology.

In The Last Decade

Weiyin Lin

14 papers receiving 352 citations

Peers

Weiyin Lin
Lisi Deng China
Weiyin Lin
Citations per year, relative to Weiyin Lin Weiyin Lin (= 1×) peers Lisi Deng

Countries citing papers authored by Weiyin Lin

Since Specialization
Citations

This map shows the geographic impact of Weiyin Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiyin Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiyin Lin more than expected).

Fields of papers citing papers by Weiyin Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiyin Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiyin Lin. The network helps show where Weiyin Lin may publish in the future.

Co-authorship network of co-authors of Weiyin Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Weiyin Lin. A scholar is included among the top collaborators of Weiyin Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiyin Lin. Weiyin Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Lin, Jiayu, et al.. (2024). Sirtuin 1 in osteoarthritis: Perspectives on regulating glucose metabolism. Pharmacological Research. 202. 107141–107141. 10 indexed citations
3.
Lin, Weiyin, et al.. (2024). Co-infection with hepatitis B and human immunodeficiency virus: epidemiology, pathogenesis, and treatment. SHILAP Revista de lepidopterología. 5(1). 56–61. 1 indexed citations
4.
Lin, Weiyin, Fengyu Hu, Haisheng Yu, et al.. (2024). Hepatic Flare Following Effective Antiretroviral Therapy Is Associated With HBsAg Seroclearance in HBV/HIV‐1 Co‐Infection. Journal of Medical Virology. 96(12). e70114–e70114.
5.
Lin, Weiyin, et al.. (2023). Early on-treatment plasma interleukin-18 as a promising indicator for long-term virological response in patients with HIV-1 infection. Frontiers in Medicine. 10. 1170208–1170208. 2 indexed citations
6.
Gong, Dandan, Weiyin Lin, Huihua Zhang, et al.. (2023). An evaluation of Mp1p antigen screening for talaromycosis in HIV-infected antiretroviral therapy-naïve population in Guangdong, China. PLoS neglected tropical diseases. 17(11). e0011785–e0011785. 5 indexed citations
7.
Lin, Weiyin, Hong Li, Fei Gu, et al.. (2023). Incidence and factors associated with hepatitis B surface antigen seroclearance in patients co-infected with HBV/HIV during antiretroviral therapy in Guangdong, China. Chinese Medical Journal. 136(22). 2686–2693. 4 indexed citations
8.
Lin, Weiyin, Chunyan Wen, Hong Li, et al.. (2022). Persistently low CD4 cell counts are associated with hepatic events in HCV/HIV coinfected patients: data from the national free antiretroviral treatment program of China. Chinese Medical Journal. 135(22). 2699–2705. 2 indexed citations
9.
Cai, Weiping, Jingliang Chen, Fengyu Hu, et al.. (2021). Persistent chronic immune activation in HIV/HBV‐coinfected patients after antiretroviral therapy. Journal of Viral Hepatitis. 28(10). 1355–1361. 8 indexed citations
10.
Xie, Zhiwei, et al.. (2020). [The efficacy and safety of lopinavir/ritonavir and arbidol in patients with coronavirus disease 2019].. PubMed. 59(8). 605–609. 24 indexed citations
11.
Li, Yueping, Zhiwei Xie, Weiyin Lin, et al.. (2020). Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial. Med. 1(1). 105–113.e4. 227 indexed citations
12.
Lei, Chunliang, Weiyin Lin, Xilong Deng, et al.. (2020). Factors associated with clinical outcomes in patients with Coronavirus Disease 2019 in Guangzhou, China. Journal of Clinical Virology. 133. 104661–104661. 9 indexed citations
13.
Chang, Chia‐Chen, et al.. (2020). Hybridization Chain Reactions Targeting the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). International Journal of Molecular Sciences. 21(9). 3216–3216. 15 indexed citations
14.
Lin, Weiyin, Zhiwei Xie, Yueping Li, et al.. (2020). Association between detectable SARS‐COV‐2 RNA in anal swabs and disease severity in patients with coronavirus disease 2019. Journal of Medical Virology. 93(2). 794–802. 33 indexed citations
15.
Ahuja, Malini, Woo Young Chung, Weiyin Lin, Beth A. McNally, & Shmuel Muallem. (2019). Ca2+ Signaling in Exocrine Cells. Cold Spring Harbor Perspectives in Biology. 12(5). a035279–a035279. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026